hurn-20201102
0001289848false00012898482020-11-022020-11-02


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_____________________
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
November 2, 2020
Date of Report (Date of earliest event reported)
_____________________
Huron Consulting Group Inc.
(Exact name of registrant as specified in its charter)
Delaware000-5097601-0666114
(State or other jurisdiction(Commission(IRS Employer
of incorporation)File Number)Identification Number)
550 West Van Buren Street
Chicago, Illinois
60607
(Address of principal executive offices)
(Zip Code)
(312) 583-8700
(Registrant’s telephone number, including area code)
_____________________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, par value $0.01 per shareHURNNASDAQ Global Select Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.




Item 2.02.    Results of Operations and Financial Condition.

On November 2, 2020, Huron Consulting Group Inc. (the "Company") issued a press release announcing its financial results for the quarter ended September 30, 2020. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

The information furnished pursuant to this Item 2.02 and the attached Exhibit 99.1 shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.

Item 2.05.    Costs Associated with Exit or Disposal Activities.

On October 29, 2020, the Company announced a restructuring plan to reduce operating costs to address the impact of the COVID-19 pandemic on its business. The restructuring plan provides for a reduction in workforce and leased office space that is expected to result in initial restructuring charges in a range of approximately $15.5 million to $19.5 million and annualized savings in a range of approximately $23.0 million to $27.0 million. The Company does not anticipate a material revenue impact related to the restructuring actions.

The reduction in workforce impacts approximately 145 employees across all segments and corporate operations. The Company expects the reduction in workforce to be substantially complete by the end of the fourth quarter of 2020 and expects to incur an estimated restructuring charge in a range of approximately $3.5 million to $4.5 million related to cash payments for employee severance and benefits.

The reduction in leased office space is expected to result in estimated non-cash restructuring charges in a range of approximately $12.0 million to $15.0 million, consisting of operating lease right-of-use asset and leasehold improvement impairment charges and accelerated depreciation on other fixed assets. The non-cash restructuring charges related to the reduction in leased office space are expected to be recorded primarily in the fourth quarter of 2020. Future cash expenditures related to the leased office space are expected to continue through 2029. The exact amount and timing of the office space reductions, and the associated payments and expenses, depend on a number of factors, including the Company’s ability to terminate or modify existing lease contracts and/or enter into sublease agreements for the exited spaces to lower future cash expenditures.

Item 9.01.    Financial Statements and Exhibits.

(d)     Exhibits
Exhibit
Number
Exhibit Description
99.1
101.INSInline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document
101.SCHInline XBRL Taxonomy Extension Schema Document
101.CALInline XBRL Taxonomy Extension Calculation Linkbase Document
101.LABInline XBRL Taxonomy Extension Label Linkbase Document
101.PREInline XBRL Taxonomy Extension Presentation Linkbase Document
101.DEFInline XBRL Taxonomy Extension Definition Linkbase Document
104Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)



SIGNATURE

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Huron Consulting Group Inc.
(Registrant)
Date:November 2, 2020/s/ John D. Kelly
John D. Kelly
Executive Vice President, Chief Financial Officer, and Treasurer


Document

Exhibit 99.1
https://cdn.kscope.io/2d84a6ff41ddfa773b9023293ae376f6-huronlogoa451a.jpg
NEWSMEDIA CONTACT
Allie Bovis
FOR IMMEDIATE RELEASEabovis@huronconsultinggroup.com
INVESTOR CONTACT
John D. Kelly
investor@huronconsultinggroup.com
Huron Announces Third Quarter 2020 Financial Results and Updates 2020 Guidance
THIRD QUARTER 2020 HIGHLIGHTS
Revenues were $205.3 million in Q3 2020 compared to $219.3 million in Q3 2019.
Net income from continuing operations was $11.1 million in Q3 2020 compared to $13.7 million in Q3 2019.
Adjusted EBITDA(7), a non-GAAP measure, was $23.6 million in Q3 2020 compared to $28.8 million in Q3 2019.
Diluted earnings per share from continuing operations was $0.50 in Q3 2020 compared to $0.61 in Q3 2019.
Adjusted diluted earnings per share from continuing operations(7), a non-GAAP measure, was $0.59 in Q3 2020 compared to $0.79 in Q3 2019.
Huron repaid $80.0 million of outstanding borrowings on the company's revolving credit facility during Q3 2020, reflecting strong cash flows during the quarter.
YEAR-TO-DATE 2020 HIGHLIGHTS AND 2020 GUIDANCE
Revenues increased $1.3 million, or 0.2%, to $645.8 million for the first nine months of 2020 from $644.5 million for the same prior year period.
Net loss from continuing operations, which includes non-cash pretax goodwill impairment charges of $59.8 million related to the company's Strategy and Innovation and Life Sciences reporting units within the Business Advisory segment incurred in Q1 2020, was $17.6 million for the first nine months of 2020 compared to net income from continuing operations of $27.6 million for the same prior year period.
Adjusted EBITDA(7), a non-GAAP measure, was $70.1 million for the first nine months of 2020 compared to $76.0 million for the same prior year period.
Diluted loss per share from continuing operations was $0.81 for the first nine months of 2020 compared to diluted earnings per share from continuing operations of $1.23 for the first nine months of 2019.
Adjusted diluted earnings per share from continuing operations(7), a non-GAAP measure, was $1.70 for the first nine months of 2020 compared to $1.95 for the first nine months of 2019.
Cash flows from operating activities were $78.0 million for the first nine months of 2020.
The company announced a restructuring plan that includes a reduction in workforce and leased office space, which is expected to result in annualized savings in a range of $23.0 million to $27.0 million. Additional cost avoidance measures, including limited annual salary increases, are expected to result in additional annualized savings. The company does not anticipate a material revenue impact related to the restructuring actions.


https://cdn.kscope.io/2d84a6ff41ddfa773b9023293ae376f6-huronlogoa451a.jpg
Huron updates its previous earnings guidance range for full year 2020, including revenue expectations in a range of $835 million to $855 million.
CHICAGO - Nov 2, 2020 - Global professional services firm Huron (NASDAQ: HURN) today announced financial results from continuing operations for the third quarter ended September 30, 2020.
“Our third-quarter performance was in line with our expectations. Growth in the Business Advisory segment reflected solid demand for our restructuring services and the acceleration of clients’ investments in technology to improve their operations, while the ongoing pandemic has continued to create disruption for our clients in the healthcare and education industries,” said James H. Roth, chief executive officer of Huron. “The current crisis presents a classic set of challenges for our clients, including how to balance addressing immediate operational issues with strategically managing for the long-term. Huron is well positioned to help our clients in this environment as we work with them to solve an increasingly complex array of issues and position their organizations for a successful future.”
COVID-19 IMPACT
The worldwide spread of the coronavirus (COVID-19) has created significant volatility, uncertainty and disruption to the global economy. The company continues to closely monitor the impact of the pandemic on all aspects of its business, including how it will impact its clients, employees and business partners. In the first nine months of 2020, some clients reprioritized and delayed projects as a result of the pandemic. This negatively impacted demand for certain services, primarily in the company's Healthcare and Education segments. Conversely, the pandemic strengthened demand for cloud-based technology and analytics solutions and certain services provided to organizations in transition within the company's Business Advisory segment.
During the third quarter of 2020, the pandemic continued to negatively impact sales and elongate the sales cycle for new opportunities for certain services, particularly within the company's Healthcare and Education segments. Therefore, the company expects the COVID-19 pandemic to continue to have an unfavorable impact on its financial results in the fourth quarter of 2020 compared to the same prior year period, which is contemplated in the updated full year 2020 guidance provided.
FOURTH QUARTER 2020 RESTRUCTURING PLAN
On October 29, 2020, the company announced a restructuring plan to reduce operating costs to address the impact of the COVID-19 pandemic on its business. The restructuring plan provides for a reduction in workforce and leased office space that is expected to result in annualized savings of approximately $23.0 million to $27.0 million. The company does not anticipate a material revenue impact related to the restructuring actions.
The reduction in workforce impacts approximately 145 employees across all segments and corporate operations. The company expects the reduction in workforce to be substantially complete by the end of the fourth quarter of 2020 and expects to incur an estimated restructuring charge in a range of approximately $3.5 million to $4.5 million related to cash payments for employee severance and benefits.
The reduction in leased office space is expected to result in estimated non-cash restructuring charges in a range of approximately $12.0 million to $15.0 million. The non-cash restructuring charges related to the reduction in leased office space are expected to be recorded primarily in the fourth quarter of 2020. Future cash expenditures related to the leased office space are expected to continue through 2029. The exact amount and timing of the office space reductions, and the associated payments and expenses, depend on a number of factors, including the company’s ability to terminate or modify existing lease contracts and/or enter into sublease agreements for the exited spaces to lower future cash expenditures.
Additional cost avoidance measures, including limiting annual salary increases, are expected to result in additional annualized savings.
In addition, the company announced its intent to divest its life sciences drug safety practice, a UK-based business that is part of the Life Sciences reporting unit within the Business Advisory segment. For the nine months ended September 30, 2020, this practice generated $1.9 million of revenue and is not significant to the company's consolidated financial statements. The company expects the divestiture to be completed in the fourth quarter of 2020.


https://cdn.kscope.io/2d84a6ff41ddfa773b9023293ae376f6-huronlogoa451a.jpg
The company believes these measures will better align delivery capacity with anticipated demand and strengthen the company’s financial position amidst the ongoing disruption, creating a foundation from which it can grow.
THIRD QUARTER 2020 RESULTS FROM CONTINUING OPERATIONS
Revenues were $205.3 million for the third quarter of 2020, compared to $219.3 million for the third quarter of 2019.
Net income from continuing operations was $11.1 million for the third quarter of 2020 compared to $13.7 million for the same quarter last year. Diluted earnings per share from continuing operations was $0.50 for the third quarter of 2020 compared to $0.61 for the third quarter of 2019.
Third quarter 2020 earnings before interest, taxes, depreciation and amortization ("EBITDA")(7) was $23.3 million compared to $28.6 million in the same prior year period.
In addition to using EBITDA to evaluate the company’s financial performance, management uses other non-GAAP financial measures, which exclude the effect of the following items (in thousands):
Three Months Ended
September 30,
20202019
Amortization of intangible assets$3,155 $4,205 
Restructuring and other charges$59 $127 
Litigation and other gains$— $(630)
Non-cash interest on convertible notes$— $2,171 
Transaction-related expenses$437 $563 
Tax effect of adjustments$(1,692)$(1,673)
Tax benefit related to "check-the-box" election$— $(736)
Foreign currency transaction losses (gains), net$(194)$114 
Adjusted EBITDA(7) was $23.6 million, or 11.5% of revenues, in the third quarter of 2020, compared to $28.8 million, or 13.1% of revenues, in the same prior year period. Adjusted net income from continuing operations(7) was $13.0 million, or $0.59 per diluted share, for the third quarter of 2020, compared to $17.7 million, or $0.79 per diluted share, for the same prior year period.
The average number of full-time billable consultants(1) increased 4.7% to 2,592 in the third quarter of 2020 from 2,476 in the same quarter last year, primarily related to hiring that occurred prior to the COVID-19 pandemic. Full-time billable consultant utilization rate(2) was 70.4% during the third quarter of 2020, compared to 76.3% during the same period last year. Average billing rate per hour for full-time billable consultants(3) was $206 for both the third quarter of 2020 and 2019. The average number of full-time equivalent professionals(5) was 360 in the third quarter of 2020, compared to 288 for the same period in 2019.
YEAR-TO-DATE 2020 RESULTS FROM CONTINUING OPERATIONS
Revenues slightly increased $1.3 million, or 0.2%, to $645.8 million for the first nine months of 2020, compared to $644.5 million for the same prior year period.
Net loss from continuing operations was $17.6 million for the first nine months of 2020, compared to net income from continuing operations of $27.6 million for the same prior year period. Diluted loss per share from continuing operations was $0.81 for the first nine months of 2020, compared to diluted earnings per share from continuing operations of $1.23 for the first nine months of 2019. Results for the first nine months of 2020 reflect non-cash pretax charges totaling $59.8 million to reduce the carrying value of goodwill in the company's Strategy and Innovation and Life Sciences reporting units within the Business Advisory segment. The impairment charges are non-cash in nature and do not affect the company's liquidity or debt covenants.
EBITDA(7) was $7.0 million for the first nine months of 2020, compared to EBITDA of $72.8 million for the first nine months of 2019.


https://cdn.kscope.io/2d84a6ff41ddfa773b9023293ae376f6-huronlogoa451a.jpg
In addition to using EBITDA to evaluate the company’s financial performance, management uses other non-GAAP financial measures, which exclude the effect of the following items (in thousands):
Nine Months Ended
September 30,
20202019
Amortization of intangible assets$9,558 $13,036 
Restructuring and other charges$2,626 $2,156 
Litigation and other gains$(150)$(1,571)
Goodwill impairment charges$59,816 $— 
Non-cash interest on convertible notes$— $6,436 
Loss on sale of business$102 $— 
Transaction-related expenses$437 $2,613 
Tax effect of adjustments$(17,041)$(5,909)
Tax benefit related to "check-the-box" election$— $(736)
Foreign currency transaction losses, net$245 $36 
Adjusted EBITDA(7) was $70.1 million, or 10.8% of revenues, for the first nine months of 2020, compared to $76.0 million, or 11.8% of revenues, for the first nine months of 2019. Adjusted net income from continuing operations(7) was $37.7 million, or $1.70 per diluted share, for the first nine months of 2020, compared to $43.7 million, or $1.95 per diluted share, for the same prior year period.
The average number of full-time billable consultants(1) increased 9.1% to 2,592 in the first nine months of 2020 from 2,376 in the first nine months of 2019, primarily related to hiring that occurred prior to the COVID-19 pandemic. Full-time billable consultant utilization rate(2) was 71.5% during the first nine months of 2020, compared to 76.5% during the same prior year period. Average billing rate per hour for full-time billable consultants(3) was $206 for the first nine months of 2020, compared to $207 for the first nine months of 2019. The average number of full-time equivalent professionals(5) was 362 in the first nine months of 2020, compared to 295 in the same prior year period.
OPERATING SEGMENTS
Huron’s results reflect a portfolio of service offerings focused on helping clients address complex business challenges.
The company’s year-to-date 2020 revenues by operating segment as a percentage of total company revenues are as follows: Healthcare (42%); Business Advisory (31%); and Education (27%). Financial results by segment are included in the attached schedules and in Huron's Quarterly Report on Form 10-Q filing for the quarter ended September 30, 2020.
OUTLOOK FOR 2020
Based on currently available information, the company is updating guidance for full year 2020 revenues before reimbursable expenses in a range of $835 million to $855 million. The company anticipates adjusted EBITDA as a percentage of revenues in a range of 10.0% to 10.5% and non-GAAP adjusted diluted earnings per share in a range of $1.95 to $2.15.
Management will provide a more detailed discussion of its outlook during the company's earnings conference call webcast.
THIRD QUARTER 2020 WEBCAST
The company will host a webcast to discuss its financial results today, November 2, 2020, at 5:00 p.m. Eastern Time (4:00 p.m. Central Time). The conference call is being webcast by NASDAQ and can be accessed from Huron's website at http://ir.huronconsultinggroup.com. A replay will be available approximately two hours after the conclusion of the webcast and for 90 days thereafter. 


https://cdn.kscope.io/2d84a6ff41ddfa773b9023293ae376f6-huronlogoa451a.jpg
USE OF NON-GAAP FINANCIAL MEASURES(7)
In evaluating the company’s financial performance and outlook, management uses EBITDA, adjusted EBITDA, adjusted EBITDA as a percentage of revenues, adjusted net income from continuing operations, and adjusted diluted earnings per share from continuing operations, which are non-GAAP measures. Management uses these non-GAAP financial measures to gain an understanding of the company's comparative operating performance (when comparing such results with previous periods or forecasts). These non-GAAP financial measures are used by management in their financial and operating decision making because management believes they reflect the company's ongoing business in a manner that allows for meaningful period-to-period comparisons. Management also uses these non-GAAP financial measures when publicly providing their business outlook, for internal management purposes, and as a basis for evaluating potential acquisitions and dispositions. Management believes that these non-GAAP financial measures provide useful information to investors and others in understanding and evaluating Huron’s current operating performance and future prospects in the same manner as management does, if they so choose, and in comparing in a consistent manner Huron’s current financial results with Huron’s past financial results. Investors should recognize that these non-GAAP measures might not be comparable to similarly titled measures of other companies. These measures should be considered in addition to, and not as a substitute for or superior to, any measure of performance, cash flows or liquidity prepared in accordance with accounting principles generally accepted in the United States.
Management has provided its outlook regarding adjusted EBITDA and non-GAAP adjusted diluted earnings per share, both of which are non-GAAP financial measures and exclude certain charges. Management has not reconciled these non-GAAP financial measures to the corresponding GAAP financial measures because guidance for the various reconciling items are not provided. Management is unable to provide guidance for these reconciling items because we cannot determine their probable significance, as certain items are outside of the company's control and cannot be reasonably predicted since these items could vary significantly from period to period. Accordingly, reconciliations to the corresponding GAAP financial measures are not available without unreasonable effort.
ABOUT HURON
Huron is a global consultancy that collaborates with clients to drive strategic growth, ignite innovation and navigate constant change. Through a combination of strategy, expertise and creativity, we help clients accelerate operational, digital and cultural transformation, enabling the change they need to own their future. By embracing diverse perspectives, encouraging new ideas and challenging the status quo, we create sustainable results for the organizations we serve. Learn more at www.huronconsultinggroup.com.
###
Statements in this press release that are not historical in nature, including those concerning the company’s current expectations about its future results, are “forward-looking” statements as defined in Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. Forward-looking statements are identified by words such as “may,” “should,” “expects,” “provides,” “anticipates,” “assumes,” “can,” “will,” “meets,” “could,” “likely,” “intends,” “might,” “predicts,” “seeks,” “would,” “believes,” “estimates,” “plans,” “continues,” “guidance,” or “outlook” or similar expressions. These forward-looking statements reflect the company's current expectations about future requirements and needs, results, levels of activity, performance, or achievements. Some of the factors that could cause actual results to differ materially from the forward-looking statements contained herein include, without limitation: the impact of the COVID-19 pandemic on the economy, our clients and client demand for our services, and our ability to sell and provide services, including the measures taken by governmental authorities and businesses in response to the pandemic, which may cause or contribute to other risks and uncertainties that we face; failure to achieve expected utilization rates, billing rates and the number of revenue-generating professionals; inability to expand or adjust our service offerings in response to market demands; our dependence on renewal of client-based services; dependence on new business and retention of current clients and qualified personnel; failure to maintain third-party provider relationships and strategic alliances; inability to license technology to and from third parties; the impairment of goodwill; various factors related to income and other taxes; difficulties in successfully integrating the businesses we acquire and achieving expected benefits from such acquisitions; risks relating to privacy, information security, and related laws and standards; and a general downturn in market conditions. These forward-looking statements involve known and unknown risks, uncertainties, and other factors, including, among others, those described under “Item 1A. Risk Factors” in Huron's Annual Report on Form 10-K for the year ended December 31, 2019, and under "Item 1A. Risk Factors" in Huron's Quarterly Report on Form 10-Q for the quarter ended September 30, 2020, that may cause actual results, levels of activity, performance or achievements to be materially different from any anticipated results, levels of activity, performance, or achievements expressed or implied by these forward-looking statements. The company disclaims any obligation to update or revise any forward-looking statements as a result of new information or future events, or for any other reason.





HURON CONSULTING GROUP INC.
CONSOLIDATED STATEMENTS OF OPERATIONS AND OTHER COMPREHENSIVE INCOME (LOSS)
(In thousands, except per share amounts)
(Unaudited)
Three Months Ended
September 30,
Nine Months Ended
September 30,
2020201920202019
Revenues and reimbursable expenses:
Revenues$205,304 $219,289 $645,780 $644,488 
Reimbursable expenses2,860 23,636 25,133 65,787 
Total revenues and reimbursable expenses208,164 242,925 670,913 710,275 
Direct costs and reimbursable expenses (exclusive of depreciation and amortization shown in operating expenses):
Direct costs145,459 143,034 451,221 422,442 
Amortization of intangible assets and software development costs1,370 1,162 4,005 3,450 
Reimbursable expenses2,840 23,571 25,095 65,897 
Total direct costs and reimbursable expenses149,669 167,767 480,321 491,789 
Operating expenses and other losses (gains), net:
Selling, general and administrative expenses38,561 48,123 126,864 151,409 
Restructuring charges59 127 1,777 2,156 
Litigation and other gains— (630)(150)(1,571)
Depreciation and amortization6,176 6,962 18,483 21,285 
Goodwill impairment charges— — 59,816 — 
Total operating expenses and other losses (gains), net44,796 54,582 206,790 173,279 
Operating income (loss)13,699 20,576 (16,198)45,207 
Other income (expense), net:
Interest expense, net of interest income(2,259)(4,374)(7,516)(13,156)
Other income (expense), net2,035 (82)687 2,830 
Total other income (expense), net(224)(4,456)(6,829)(10,326)
Income (loss) from continuing operations before taxes13,475 16,120 (23,027)34,881 
Income tax expense (benefit)2,388 2,414 (5,413)7,256 
Net income (loss) from continuing operations11,087 13,706 (17,614)27,625 
Loss from discontinued operations, net of tax(29)(52)(89)(195)
Net income (loss)$11,058 $13,654 $(17,703)$27,430 
Net earnings (loss) per basic share:
Net income (loss) from continuing operations$0.50 $0.62 $(0.81)$1.26 
Loss from discontinued operations, net of tax— — — (0.01)
Net income (loss)$0.50 $0.62 $(0.81)$1.25 
Net earnings (loss) per diluted share:
Net income (loss) from continuing operations$0.50 $0.61 $(0.81)$1.23 
Loss from discontinued operations, net of tax— — — (0.01)
Net income (loss)$0.50 $0.61 $(0.81)$1.22 
Weighted average shares used in calculating earnings (loss) per share:
Basic21,905 22,052 21,868 21,973 
Diluted22,175 22,561 21,868 22,425 
Comprehensive income:
Net income (loss)$11,058 $13,654 $(17,703)$27,430 
Foreign currency translation adjustments, net of tax381 (630)(294)(673)
Unrealized gain (loss) on investment, net of tax4,885 1,168 (1,051)7,740 
Unrealized loss on cash flow hedging instruments, net of tax(243)(149)(3,633)(998)
Other comprehensive income (loss)5,023 389 (4,978)6,069 
Comprehensive income (loss)$16,081 $14,043 $(22,681)$33,499 





HURON CONSULTING GROUP INC.
CONSOLIDATED BALANCE SHEETS
(In thousands, except share and per share amounts)
(Unaudited)
 
September 30,
2020
December 31,
2019
Assets
Current assets:
Cash and cash equivalents$74,745 $11,604 
Receivables from clients, net94,644 116,571 
Unbilled services, net78,346 79,937 
Income tax receivable244 2,376 
Prepaid expenses and other current assets11,853 14,248 
Total current assets259,832 224,736 
Property and equipment, net34,879 38,413 
Deferred income taxes, net11,425 1,145 
Long-term investments66,122 54,541 
Operating lease right-of-use assets50,499 54,954 
Other non-current assets58,944 52,177 
Intangible assets, net22,250 31,625 
Goodwill586,730 646,680 
Total assets$1,090,681 $1,104,271 
Liabilities and stockholders’ equity
Current liabilities:
Accounts payable$4,838 $7,944 
Accrued expenses and other current liabilities23,646 18,554 
Accrued payroll and related benefits105,276 141,605 
Current maturities of long-term debt540 529 
Current maturities of operating lease liabilities9,058 7,469 
Deferred revenues31,768 28,443 
Total current liabilities175,126 204,544 
Non-current liabilities:
Deferred compensation and other liabilities44,699 28,635 
Long-term debt, net of current portion250,917 208,324 
Operating lease liabilities, net of current portion64,318 69,233 
Deferred income taxes, net555 8,070 
Total non-current liabilities360,489 314,262 
Commitments and contingencies
Stockholders’ equity
Common stock; $0.01 par value; 500,000,000 shares authorized; 25,444,128 and 25,144,764 shares issued at September 30, 2020 and December 31, 2019, respectively247 247 
Treasury stock, at cost, 2,571,266 and 2,425,430 shares at September 30, 2020 and December 31, 2019, respectively(129,438)(128,348)
Additional paid-in capital454,153 460,781 
Retained earnings220,146 237,849 
Accumulated other comprehensive income9,958 14,936 
Total stockholders’ equity555,066 585,465 
Total liabilities and stockholders’ equity$1,090,681 $1,104,271 






HURON CONSULTING GROUP INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
(Unaudited) 
Nine Months Ended
September 30,
20202019
Cash flows from operating activities:
Net income (loss)$(17,703)$27,430 
Adjustments to reconcile net income (loss) to cash flows from operating activities:
Depreciation and amortization22,511 25,410 
Non-cash lease expense5,844 6,413 
Lease impairment charge— 805 
Share-based compensation18,559 18,094 
Amortization of debt discount and issuance costs595 8,066 
Goodwill impairment charges59,816 — 
Allowances for doubtful accounts539 191 
Deferred income taxes(16,125)(262)
Loss on sale of business102 — 
Change in fair value of contingent consideration liabilities— (1,506)
Changes in operating assets and liabilities, net of divestiture:
(Increase) decrease in receivables from clients, net23,493 (6,817)
(Increase) decrease in unbilled services, net1,597 (30,163)
(Increase) decrease in current income tax receivable / payable, net9,455 10,561 
(Increase) decrease in other assets(3,426)(4,160)
Increase (decrease) in accounts payable and other liabilities(5,272)(3,565)
Increase (decrease) in accrued payroll and related benefits(25,290)(1,850)
Increase (decrease) in deferred revenues3,290 3,098 
Net cash provided by operating activities77,985 51,745 
Cash flows from investing activities:
Purchases of property and equipment, net(5,731)(10,024)
Purchases of investment securities(13,000)— 
Investment in life insurance policies(2,026)(4,434)
Purchases of businesses(801)(2,500)
Capitalization of internally developed software costs(6,830)(7,462)
Net cash used in investing activities(28,388)(24,420)
Cash flows from financing activities:
Proceeds from exercise of stock options825 703 
Shares redeemed for employee tax withholdings(7,797)(5,206)
Share repurchases(22,115)— 
Proceeds from bank borrowings283,000 105,500 
Repayments of bank borrowings(240,396)(105,885)
Payment of debt issuance costs— (1,498)
Payments for contingent consideration liabilities— (4,674)
Net cash provided by (used in) financing activities13,517 (11,060)
Effect of exchange rate changes on cash27 38 
Net increase in cash and cash equivalents63,141 16,303 
Cash and cash equivalents at beginning of the period11,604 33,107 
Cash and cash equivalents at end of the period$74,745 $49,410 



HURON CONSULTING GROUP INC.
SEGMENT OPERATING RESULTS AND OTHER OPERATING DATA
(Unaudited)
Three Months Ended
September 30,
Percent
Increase
(Decrease)
Segment and Consolidated Operating Results (in thousands):20202019
Healthcare:
Revenues$87,406 $100,000 (12.6)%
Operating income$25,610 $32,863 (22.1)%
Segment operating income as a percentage of segment revenues29.3 %32.9 %
Business Advisory:
Revenues$66,048 $62,519 5.6 %
Operating income$10,780 $11,942 (9.7)%
Segment operating income as a percentage of segment revenues16.3 %19.1 %
Education:
Revenues$51,850 $56,770 (8.7)%
Operating income$12,548 $14,413 (12.9)%
Segment operating income as a percentage of segment revenues24.2 %25.4 %
Total Company:
Revenues$205,304 $219,289 (6.4)%
Reimbursable expenses2,860 23,636 (87.9)%
Total revenues and reimbursable expenses$208,164 $242,925 (14.3)%
Statements of Operations reconciliation:
Segment operating income$48,938 $59,218 (17.4)%
Items not allocated at the segment level:
Other operating expenses29,042 32,310 (10.1)%
Litigation and other gains— (630)N/M
Depreciation and amortization6,197 6,962 (11.0)%
Total operating income (loss)13,699 20,576 (33.4)%
Other expense, net(224)(4,456)(95.0)%
Income from continuing operations before taxes$13,475 $16,120 (16.4)%
Other Operating Data:
Number of full-time billable consultants (at period end) (1):
Healthcare838 886 (5.4)%
Business Advisory1,001 954 4.9 %
Education790 727 8.7 %
Total2,629 2,567 2.4 %
Average number of full-time billable consultants (for the period) (1):
Healthcare844 858 
Business Advisory976 920 
Education772 698 
Total2,592 2,476 






HURON CONSULTING GROUP INC.
SEGMENT OPERATING RESULTS AND OTHER OPERATING DATA (CONTINUED)
(Unaudited)
 Three Months Ended September 30,
Other Operating Data (continued):20202019
Full-time billable consultant utilization rate (2):
Healthcare71.4 %81.8 %
Business Advisory72.6 %72.0 %
Education66.5 %75.5 %
Total70.4 %76.3 %
Full-time billable consultant average billing rate per hour (3):
Healthcare$252 $226 
Business Advisory (4)
$186 $193 
Education$184 $197 
Total (4)
$206 $206 
Revenue per full-time billable consultant (in thousands):
Healthcare$77 $84 
Business Advisory$64 $65 
Education$57 $70 
Total$66 $73 
Average number of full-time equivalents (for the period) (5):
Healthcare279 217 
Business Advisory35 19 
Education46 52 
Total360 288 
Revenue per full-time equivalent (in thousands):
Healthcare$80 $128 
Business Advisory$106 $126 
Education$165 $151 
Total$93 $132 





HURON CONSULTING GROUP INC.
SEGMENT OPERATING RESULTS AND OTHER OPERATING DATA (CONTINUED)
(Unaudited)
Nine Months Ended
September 30,
Percent
Increase
(Decrease)
Segment and Consolidated Operating Results (in thousands):20202019
Healthcare:
Revenues$268,340 $295,621 (9.2)%
Operating income$70,831 $94,058 (24.7)%
Segment operating income as a percentage of segment revenues26.4 %31.8 %
Business Advisory:
Revenues$201,423 $183,602 9.7 %
Operating income$37,306 $32,997 13.1 %
Segment operating income as a percentage of segment revenues18.5 %18.0 %
Education:
Revenues$176,017 $165,265 6.5 %
Operating income$41,792 $43,235 (3.3)%
Segment operating income as a percentage of segment revenues23.7 %26.2 %
Total Company:
Revenues$645,780 $644,488 0.2 %
Reimbursable expenses25,133 65,787 (61.8)%
Total revenues and reimbursable expenses$670,913 $710,275 (5.5)%
Statements of Operations reconciliation:
Segment operating income$149,929 $170,290 (12.0)%
Items not allocated at the segment level:
Other operating expenses87,826 105,369 (16.6)%
Litigation and other gains(150)(1,571)(90.5)%
Depreciation and amortization18,635 21,285 (12.5)%
Goodwill impairment charges (6)
59,816 — N/M
Total operating income (loss)(16,198)45,207 N/M
Other expense, net(6,829)(10,326)(33.9)%
Income (loss) from continuing operations before taxes$(23,027)$34,881 N/M
Other Operating Data:
Number of full-time billable consultants (at period end) (1):
Healthcare838 886 (5.4)%
Business Advisory1,001 954 4.9 %
Education790 727 8.7 %
Total2,629 2,567 2.4 %
Average number of full-time billable consultants (for the period) (1):
Healthcare873 835 
Business Advisory940 876 
Education779 665 
Total2,592 2,376 






HURON CONSULTING GROUP INC.
SEGMENT OPERATING RESULTS AND OTHER OPERATING DATA (CONTINUED)
(Unaudited)
 Nine Months Ended
September 30,
Other Operating Data (continued):20202019
Full-time billable consultant utilization rate (2):
Healthcare70.2 %80.4 %
Business Advisory72.6 %72.7 %
Education71.7 %76.7 %
Total71.5 %76.5 %
Full-time billable consultant average billing rate per hour (3):
Healthcare$233 $225 
Business Advisory (4)
$197 $195 
Education$189 $200 
Total (4)
$206 $207 
Revenue per full-time billable consultant (in thousands):
Healthcare$216 $247 
Business Advisory$204 $202 
Education$194 $217 
Total$205 $222 
Average number of full-time equivalents (for the period) (5):
Healthcare279 237 
Business Advisory27 14 
Education56 44 
Total362 295 
Revenue per full-time equivalent (in thousands):
Healthcare$285 $375 
Business Advisory$370 $465 
Education$453 $480 
Total$317 $395 
(1)Consists of full-time professionals who provide consulting services and generate revenues based on the number of hours worked.
(2)Utilization rate for full-time billable consultants is calculated by dividing the number of hours full-time billable consultants worked on client assignments during a period by the total available working hours for these consultants during the same period, assuming a forty-hour work week, less paid holidays and vacation days.
(3)Average billing rate per hour for full-time billable consultants is calculated by dividing revenues for a period by the number of hours worked on client assignments during the same period.
(4)The Business Advisory segment includes operations of Huron Eurasia India. Absent the impact of Huron Eurasia India, the average billing rate per hour for the Business Advisory segment would have been $201 and $221 for the three months ended September 30, 2020 and 2019, respectively; and $217 and $220 for the nine months ended September 30, 2020 and 2019, respectively.
Absent the impact of Huron Eurasia India, Huron's consolidated average billing rate per hour would have been $212 and $216 for the three months ended September 30, 2020 and 2019, respectively; and $213 and $216 for the nine months ended September 30, 2020 and 2019, respectively.
(5)Consists of coaches and their support staff within the Culture and Organizational Excellence solution, consultants who work variable schedules as needed by clients, employees who provide managed services in our Healthcare segment, and full-time employees who provide software support and maintenance services to clients.
(6)The non-cash goodwill impairment charges are not allocated at the segment level because the underlying goodwill asset is reflective of our corporate investment in the segments. We do not include the impact of goodwill impairment charges in our evaluation of segment performance.
N/M - Not Meaningful



HURON CONSULTING GROUP INC.
RECONCILIATION OF NET INCOME (LOSS) FROM CONTINUING OPERATIONS
TO ADJUSTED EARNINGS BEFORE INTEREST, TAXES, DEPRECIATION AND AMORTIZATION (7)
(In thousands)
(Unaudited)
 Three Months Ended
September 30,
Nine Months Ended
September 30,
 2020201920202019
Revenues$205,304 $219,289 $645,780 $644,488 
Net income (loss) from continuing operations$11,087 $13,706 $(17,614)$27,625 
Add back:
Income tax expense (benefit)2,388 2,414 (5,413)7,256 
Interest expense, net of interest income2,259 4,374 7,516 13,156 
Depreciation and amortization7,546 8,124 22,488 24,735 
Earnings before interest, taxes, depreciation and amortization (EBITDA) (7)
23,280 28,618 6,977 72,772 
Add back:
Restructuring and other charges59 127 2,626 2,156 
Litigation and other gains— (630)(150)(1,571)
Goodwill impairment charges— — 59,816 — 
Loss on sale of business— — 102 — 
Transaction-related expenses437 563 437 2,613 
Foreign currency transaction losses (gains), net(194)114 245 36 
Adjusted EBITDA (7)
$23,582 $28,792 $70,053 $76,006 
Adjusted EBITDA as a percentage of revenues (7)
11.5 %13.1 %10.8 %11.8 %




HURON CONSULTING GROUP INC.
RECONCILIATION OF NET INCOME (LOSS) FROM CONTINUING OPERATIONS
TO ADJUSTED NET INCOME FROM CONTINUING OPERATIONS (7)
(In thousands, except per share amounts)
(Unaudited)
Three Months Ended
September 30,
Nine Months Ended
September 30,
 2020201920202019
Net income (loss) from continuing operations$11,087 $13,706 $(17,614)$27,625 
Weighted average shares - diluted22,175 22,561 21,868 22,425 
Diluted earnings (loss) per share from continuing operations$0.50 $0.61 $(0.81)$1.23 
Add back:
Amortization of intangible assets3,155 4,205 9,558 13,036 
Restructuring and other charges59 127 2,626 2,156 
Litigation and other gains— (630)(150)(1,571)
Goodwill impairment charges— — 59,816 — 
Non-cash interest on convertible notes— 2,171 — 6,436 
Loss on sale of business— — 102 — 
Transaction-related expenses437 563 437 2,613 
Tax effect of adjustments(1,692)(1,673)(17,041)(5,909)
Tax benefit related to "check-the-box" election— (736)— (736)
Total adjustments, net of tax1,959 4,027 55,348 16,025 
Adjusted net income from continuing operations (7)
$13,046 $17,733 $37,734 $43,650 
Adjusted weighted average shares - diluted (8)
22,175 22,561 22,207 22,425 
Adjusted diluted earnings per share from continuing operations (7)
$0.59 $0.79 $1.70 $1.95 

(7)    In evaluating the company’s financial performance and outlook, management uses earnings before interest, taxes, depreciation and amortization (“EBITDA”), adjusted EBITDA, adjusted EBITDA as a percentage of revenues, adjusted net income from continuing operations, and adjusted diluted earnings per share from continuing operations, which are non-GAAP measures. Management uses these non-GAAP financial measures to gain an understanding of the company's comparative operating performance (when comparing such results with previous periods or forecasts). These non-GAAP financial measures are used by management in their financial and operating decision making because management believes they reflect the company's ongoing business in a manner that allows for meaningful period-to-period comparisons. Management also uses these non-GAAP financial measures when publicly providing the company's business outlook, for internal management purposes, and as a basis for evaluating potential acquisitions and dispositions. Management believes that these non-GAAP financial measures provide useful information to investors and others in understanding and evaluating Huron’s current operating performance and future prospects in the same manner as management does, if they so choose, and in comparing in a consistent manner Huron’s current financial results with Huron’s past financial results. Investors should recognize that these non-GAAP measures might not be comparable to similarly titled measures of other companies. These measures should be considered in addition to, and not as a substitute for or superior to, any measure of performance, cash flows or liquidity prepared in accordance with accounting principles generally accepted in the United States.
(8)    As the company reported a net loss for the nine months ended September 30, 2020, GAAP diluted weighted average shares outstanding equals the basic weighted average shares outstanding for that period. The non-GAAP adjustments described above resulted in adjusted net income from continuing operations for the first nine months of 2020. Therefore, dilutive common stock equivalents have been included in the calculation of adjusted diluted weighted average shares outstanding.